Characterization of promoters in tuning constructs in T-Rex cells
Dual Luciferase Assay
Characterization of BBa_K337035 and BBa_K337036 in different cell lines
If BBa_K337035 and BBa_K337036 are transfected into different cell lines it is obvious that Hek293T cells are the easiest to transfect with both constructs an expression of 17-22 RLU is to be measured. Hek T-Rex cells are showing and expression level of 12 RLU of both constructs. Hela cells are also showing constant expression levels of 8 RLU with both constructs. A rather low expression of 2RLU is to be seen by transfecting the 2 constructs in Huh7 cells. This might be due to low transfection efficiency of this cell line in general. All together it is to say that BBa_K337035 and BBa_K337036 show comparable expression.
Characterization of part binding sites (BBa_K337052, BBa_K337053, BBa_K337054)
Regulation of gene expression can be achieved by fusing miRNA binding sites into the 3'UTR of a GOI. In case a referring shRNA miR is endogenously present or co-expressed, the GOI is knocked down. Strength of regulation thereby depends on binding site properties. We are able to tune gene expression linearly over a broad range. This is a first proof of principle for various miRNA-mRNA interaction in vitro. Therefore, we transfected HeLa cells in principle with our pSMB_miTuner Plasmid HD3 . It turned out, that no obvious effect of different binding sites on reporter gene expression could be measured (data not shown). We assume that the RSV promoter driving the shRNA miR is too weak for tight regulation of the referring binding site behind the GOI. Only if a sufficient amount of shRNA miR binds to its target, translation is significantly repressed. Thus, we expressed the shRNA miR from a separate plasmid which was always co-transfected with the original tuning construct. The reporter genes - i. e. Luc2 and hRluc - were also expressed from separate plasmids to get a reference as well as a transfection control. This was achieved by co-transfection the tuning construct with corresponding shRNA miRhaat and as a control a miRNA w/o binding sites in the target 3'UTR. The experiment was done in a 96-well plate by plating 5000 Hela cells/well 24h before transfection. Transfection was done using Fugene transfection reagent. 2.5ng of tuning construct were co-transfected with the shRNA miR construct of a concentration of 25 ng (1:10). Then, we conducted a Dual Luciferase Assay for quantification of gene expression. The data preciously shows a tuned expression from almost 0% to 100% (Fig. 1, Fig. 2). Lowest expression refers to complete knockdown through cloning of perfect binding sites into the 3'UTR to the reporter gene(always green bar on the left hand side of the figures). 100% refers to ordinary expression from a construct without binding sites (always orange column on the right hand side of the figures). In presence of the specific shRNA miR, gene expression was mediated to various levels through interactions with the different imperfect binding sites. Whereas, when an unspecific shRNA miR was expressed, gene expression remained unaffected (see raw data below). The latter aspect reveals, that the binding sites were correctly designed, since they seem to interact specifically with a referring shRNA miR. The constructs were tested in two different backbones: pBS_U6 and pBS_H1. Both are in viral context, meaning that they contain inverted terminal repeats (ITRs). The constructs can be packed into the capsid of an adeno-associated virus (AAV). We chose the data obtained by the construct with the U6 promoter as this promoter is more efficient than the H1 promoter, ensuring that the system is saturated and ensuring that the data is reproducible. The same constructs were also used for virus production to infect cells even more efficiently as compared to transfections. Because of the significant data, we decided to inject the viruses into mice to see the tuning effect also in vivo. The pBS_H1 construct should be used for mice injections since the expressed shRNA miR against human alpha-1-antitrypsine (hAAT) is cytotoxic in higher concentrations. The pBS_H1 backbone leads to moderate expression ranges, still obviously showing the tuning effect.
Strikingly, the order of constructs in terms of knockdown for the imperfect binding sites is similar. The perfect binding site BBa_K337052 shows knockdown of about 96%. point mut 10 (1), point mut 10 (2) and point mut 11 BBa_K337053 (2) always show strong knockdown, whereas bulge 16-18 BBa_K337054 , only seed and bulge 9-12(2) show only loose down-regulation. Consulting the binding site sequences, the weak knockdown can be addressed to bulges in the supplementary region or complete lack of the 3' region of the binding site. Still high strength could be maintained due to only single nucleotide exchanges in the central region of the binding site.
Characterization of synthetic single microRNA binding sites (BBa_K337055)
Binding sites for miR122 were experimentally characterized by cloning them into psiCHECK-2 backbone (Promega). Dual luciferase assay was conducted using this time Renilla Luciferase as a reporter and the other luciferase as a reference for normalization. Figure 3 shows again a broad range of regulation depending on binding site sequence properties. BBa_K337055 (mut 99) is the construct with the perfect binding site and leads to an knock-down percentage of 96%. BBa_K337056 (mut 7) is an imperfect binding site which leads to a knockdown percentage of 64%. BBa_K337057(mut 111) is an imperfect binding site with a knockdown efficiency of 24%. All this contributes to a real tuning effect by introducing binding sites with introduced mismatches following the rational design protocol.
Characterization of synthetic microRNA binding site patterns against endogenous miR122 3.1BBa_K337008 and 1.3 BBa_K337000
We used the miMeasure plasmid with the BB-2 standard to characterise binding sites for the endogenously expressed miR122. We cloned two different synthetic microRNA binding site patterns into our miMeasure construct plasmid: 3.1 BBa_K337008 and 1.3 BBa_K337000. As the binding site is inserted downstream of green fluorescent protein (EGFP), a regulation of EGFP expression is to be expected. miMeasure normalizes knockdown of EGFP to the unregulated blue fluorescent protein (EBFP2). By calculating the ratio of EGFP to EBFP2 we determined the knockdown percentage characteristic of the binding site patterns.
We tested these constructs in four different set-ups with three different cell lines:
EGFP to EBFP2 ratios were measured with flow cytometry and microscopy. Measurement results for the four cell lines and the binding sites 3.1 BBa_K337008 and 1.3 BBa_K337000 are shown in Fig. 4 for all four cell line setups. As expected, no down regulation of EGFP expression was measured in HeLa cells due to the lack of miR122 therein. This serves as a control for the design of our binding sites as it is clear that they do not cross-react with other endogenously expressed miRNAs but are specific for miR122. Similarly, no down regulation was observed in HepG2 cells. The levels of miR122 expression in those cells are reportedly reduced by 99.5&, therefore also serving as a negative control. Both the construct 1.3 (containing two perfect binding sites with the extra 10bp spacer in between) and 3.1 (containing 3 perfect binding sites) lead to an increase in downregulation effect of EGFP in Huh7 cells and in HeLa cells cotransfected with miR122 in comparison to the single perfect binding site.
Characterization of the bidirectional CMV promoter
The bidirectional CMV promoter BBa_K337017 is a new standard part out of our miMeasure construct. The promoter was used to express two reporter genes with a comparable transcription rate. Referring to the figures below, this is the case.